Incyte (INCY) Short term Debt (2012 - 2026)
Incyte posted quarterly Short term Debt of $39.4 million for Q1 2026, down 5.59% year-on-year from $41.7 million in Q1 2025, and down 4.28% on a QoQ basis from $41.1 million in Q4 2025.
Incyte (INCY) has 14 years of Short term Debt data on file, last reported at $39.4 million in Q1 2026.
- For the quarter ending Q1 2026, Short term Debt fell 5.59% year-over-year to $39.4 million; the trailing twelve-month figure through Mar 2026 stood at $39.4 million (down 5.59% YoY), and the FY2025 full-year result was $41.1 million, up 4.86% from the prior year.
- Short term Debt for Q1 2026 stood at $39.4 million, down from $41.1 million in the prior quarter.
- Across five years, Short term Debt topped out at $46.8 million in Q2 2025 and bottomed at $34.2 million in Q3 2022.
- The 5-year median for Short term Debt is $37.9 million (2022), against an average of $39.1 million.
- The widest annual swing landed in 2022, when Short term Debt retreated 10.55%; it then advanced 26.07% in 2025.
- A 5-year view of Short term Debt shows it stood at $36.5 million in 2022, then rose by 5.16% to $38.4 million in 2023, then rose by 2.12% to $39.2 million in 2024, then climbed by 4.86% to $41.1 million in 2025, then declined by 4.28% to $39.4 million in 2026.
- The last three Short term Debt figures came in at $39.4 million (Q1 2026), $41.1 million (Q4 2025), and $45.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.38 Mn |
| Dec 31, 2025 | 41.14 Mn |
| Sep 30, 2025 | 45.62 Mn |
| Jun 30, 2025 | 46.84 Mn |
| Mar 31, 2025 | 41.72 Mn |
| Dec 31, 2024 | 39.24 Mn |
| Sep 30, 2024 | 40.34 Mn |
| Jun 30, 2024 | 37.16 Mn |
| Mar 31, 2024 | 37.16 Mn |
| Dec 31, 2023 | 38.42 Mn |
| Sep 30, 2023 | 36.82 Mn |
| Jun 30, 2023 | 37.51 Mn |
| Mar 31, 2023 | 37.17 Mn |
| Dec 31, 2022 | 36.54 Mn |
| Sep 30, 2022 | 34.19 Mn |
| Jun 30, 2022 | 36.92 Mn |
| Mar 31, 2022 | 37.87 Mn |
| Dec 31, 2021 | 37.01 Mn |
| Sep 30, 2021 | 38.22 Mn |
| Jun 30, 2021 | 39.99 Mn |
| Mar 31, 2021 | 39.91 Mn |
| Dec 31, 2020 | 38.40 Mn |
| Sep 30, 2020 | 39.05 Mn |
| Jun 30, 2020 | 18.59 Mn |
| Mar 31, 2020 | 18.52 Mn |
| Dec 31, 2019 | 34.04 Mn |
| Jun 30, 2019 | 35.93 Mn |
| Mar 31, 2019 | 34.24 Mn |
| Dec 31, 2018 | 31.84 Mn |
| Sep 30, 2018 | 7.65 Mn |
| Jun 30, 2018 | 7.55 Mn |
| Mar 31, 2018 | 28.18 Mn |
| Dec 31, 2017 | 7.39 Mn |
| Sep 30, 2017 | 24.33 Mn |
| Jun 30, 2017 | 22.78 Mn |
| Mar 31, 2017 | 21.53 Mn |
| Dec 31, 2016 | 19.54 Mn |
| Sep 30, 2016 | 17.85 Mn |
| Jun 30, 2016 | 17.69 Mn |
| Sep 30, 2015 | 5,000.00 |
| Jun 30, 2015 | 42.94 Mn |
| Mar 31, 2015 | 87.34 Mn |
| Dec 31, 2014 | 85.19 Mn |
| Sep 30, 2012 | 9.82 Mn |
| Jun 30, 2012 | 9.68 Mn |
| Mar 31, 2012 | 9.55 Mn |